Overbeck Christian Takou Mbah
Resident in Medicine
All Publications
-
Cost-Effectiveness of Telemedicine-Based Screening Programs for Retinopathy of Prematurity in Low- and Middle-Income Countries.
Ophthalmology science
2026; 6 (11): 101395
Abstract
Evaluate the cost-effectiveness of telemedicine-based retinopathy of prematurity (ROP) screening strategies compared with binocular indirect ophthalmoscopy (BIO) and the current standard of care (no screening) in Sub-Saharan Africa.Decision-analytic cost-effectiveness analysis simulating costs and vision outcomes across alternative ROP screening strategies.A simulated cohort of 10 000 qualifying preterm infants (birth weight ≤2000 g or gestational age ≤32 weeks) in neonatal intensive care units across Ghana were modeled for each screening strategy.Three strategies were compared: no screening, BIO, and telemedicine-based screening with nonphysician graders. A hybrid telemedicine approach with 10% of images graded by physicians was also evaluated. The model estimated disease detection, treatment, and vision outcomes, and calculated costs and quality-adjusted life years (QALYs). Sensitivity analyses varied nonphysician grader specificity, ROP incidence, and physician evaluation time for BIO. A willingness-to-pay threshold of $2238 per QALY (1× Ghana's GDP per capita) was applied.Incremental cost-effectiveness ratios expressed as cost per QALY gained and dominance relationships among strategies.Compared with no screening, telemedicine-based screening with nonphysician graders yielded health benefits at a cost of $27 per QALY gained. Incorporating 10% physician grading into the telemedicine platform further improved outcomes at $1331 per QALY gained relative to nonphysician grading alone. Binocular indirect ophthalmoscopy was strongly dominated by the hybrid telemedicine strategy. Sensitivity analyses identified nonphysician grader specificity, disease incidence, and physician evaluation time for BIO as the most influential parameters; overall conclusions were robust across plausible ranges.Telemedicine-based ROP screening, particularly a hybrid approach incorporating limited physician grading, appears to be a cost-effective strategy for implementation in Ghana and may be applicable to other countries in Sub-Saharan Africa.Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.
View details for DOI 10.1016/j.xops.2026.101395
View details for PubMedID 42861005
View details for PubMedCentralID PMC13654025
-
Low parental income level is associated with pediatric COVID-19 vaccine hesitancy in the San Francisco Bay area.
BMC public health
2025; 25 (1): 921
Abstract
To characterize the differences between COVID-19 vaccine-hesitant and vaccine-accepting parents in the Bay Area.We analyzed a cross-sectional survey of 251 parents of children (< 18 years) from six San Francisco Bay Area counties in November of 2022. We adapted WHO's Vaccine Hesitancy Scale (VHS) into a 9-item Likert scale measuring COVID-19 vaccine hesitancy. We assigned a VHS score to each participant, with lower VHS scores indicating higher vaccine hesitancy. We performed multiple linear regression analyses with VHS scores and children's vaccination status as outcomes and demographic factors as predictors.Parents of children who had received at least one dose of the COVID-19 vaccine had a 17.1% higher VHS score compared to parents of children who had not received any dose (p < 0.01). Additionally, parents with annual income <$50,000 had a 9.6% lower VHS score compared to parents with income > $150,000 (p < 0.01), indicating higher vaccine hesitancy in lower-income parents.Low-income parents appear to be more vaccine-hesitant than high-income parents in the Bay Area. Future public health interventions should focus on lower-income parents to improve vaccine uptake.
View details for DOI 10.1186/s12889-025-22132-5
View details for PubMedID 40055641
View details for PubMedCentralID PMC11889740
-
Identification of Highly Cross-Reactive Mimotopes for a Public T Cell Response in Murine Melanoma
FRONTIERS IN IMMUNOLOGY
2022; 13: 886683
Abstract
While immune checkpoint blockade results in durable responses for some patients, many others have not experienced such benefits. These treatments rely upon reinvigorating specific T cell-antigen interactions. However, it is often unknown what antigens are being recognized by T cells or how to potently induce antigen-specific responses in a broadly applicable manner. Here, we characterized the CD8+ T cell response to a murine model of melanoma following combination immunotherapy to determine the basis of tumor recognition. Sequencing of tumor-infiltrating T cells revealed a repertoire of highly homologous TCR sequences that were particularly expanded in treated mice and which recognized an antigen from an endogenous retrovirus. While vaccination against this peptide failed to raise a protective T cell response in vivo, engineered antigen mimotopes induced a significant expansion of CD8+ T cells cross-reactive to the original antigen. Vaccination with mimotopes resulted in killing of antigen-loaded cells in vivo yet showed modest survival benefit in a prophylactic vaccine paradigm. Together, this work demonstrates the identification of a dominant tumor-associated antigen and generation of mimotopes which can induce robust functional T cell responses that are cross-reactive to the endogenous antigen across multiple individuals.
View details for DOI 10.3389/fimmu.2022.886683
View details for Web of Science ID 000821851400001
View details for PubMedID 35812387
View details for PubMedCentralID PMC9260506
-
HLA class-I-peptide stability mediates CD8(+) T cell immunodominance hierarchies and facilitates HLA-associated immune control of HIV
CELL REPORTS
2021; 36 (2): 109378
Abstract
Defining factors that govern CD8+ T cell immunodominance is critical for the rational design of vaccines for viral pathogens. Here, we assess the contribution of human leukocyte antigen (HLA) class-I-peptide stability for 186 optimal HIV epitopes across 18 HLA alleles using transporter associated with antigen processing (TAP)-deficient mono-allelic HLA-expressing cell lines. We find that immunodominant HIV epitopes increase surface stabilization of HLA class-I molecules in comparison to subdominant epitopes. HLA class-I-peptide stability is also strongly correlated with overall immunodominance hierarchies, particularly for epitopes from high-abundance proteins (e.g., Gag). Moreover, HLA alleles associated with HIV protection are preferentially stabilized by epitopes derived from topologically important viral regions at a greater frequency than neutral and risk alleles. These findings indicate that relative stabilization of HLA class-I is a key factor for CD8+ T cell epitope immunodominance hierarchies, with implications for HIV control and the design of T-cell-based vaccines.
View details for DOI 10.1016/j.celrep.2021.109378
View details for Web of Science ID 000672741900034
View details for PubMedID 34260940
View details for PubMedCentralID PMC8293625